Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy.

The results illustrated in Figure 1 B show that at progression, an increase in the level of miR-1246 and a decrease in that of miR-485-3p were detectable, even though the differences did not reach statistical significance.

also in 111,027 other papers